Tag Archives: ondansetron

No Trials, but Many Tribulations Over Zofran (ondansetron): Drug Safety System Putting Children In-Utero at Risk

Alabama mother Marquita Smiley began taking the generic form of anti-nausea drug Zofran (ondansetron) regularly during her first trimester to treat debilitating morning sickness—but when her son Zaidan was born with a critically underdeveloped heart, necessitating open heart surgery at just 3 days old, Marquita started to wonder whether the drug she took might have been …. Read More

Comments Off on No Trials, but Many Tribulations Over Zofran (ondansetron): Drug Safety System Putting Children In-Utero at Risk

Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

At the April 2016 Mass Torts Made Perfect conference in Las Vegas later this month, Grant & Eisenhofer Director Elizabeth Graham, co-lead on the Plaintiffs’ Executive Committee of the Zofran (ondansetron) multi-district litigation, will speak to the latest developments in the litigation. Ms. Graham will cover the status of the over 230 cases centralized before …. Read More

Comments Off on Grant & Eisenhofer’s Beth Graham to Speak on Zofran (ondansetron) Litigation

Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL

In March 2016, with more than 200 lawsuits pending in the Zofran (ondansetron) federal multi-district litigation (“MDL”) in the District of Massachusetts, plaintiffs submitted their proposal on the sequence and effect of “Master Pleadings.” In a sequence of master pleadings, usually created for administrative reasons, master complaints collate claims brought in each case into a single …. Read More

Comments Off on Plaintiffs Submit Proposal on Master Pleadings in Zofran (ondansetron) MDL

Zofran (ondansetron) MDL Continues to Grow

More and more parents are filing lawsuits against GlaxoSmithKline LLC (“GSK”), maker of anti-nausea drug Zofran (ondansetron), after their children exposed to the drug were born with birth defects. The drug, approved by the FDA to only treat nausea and vomiting in cancer patients undergoing chemotherapy and patients who had major surgeries, has been marketed …. Read More

Comments Off on Zofran (ondansetron) MDL Continues to Grow

New Study Finds Off-Label Prescription Drug Use Increases Likelihood of Adverse Events

A new study out of the Journal of the American Medical Association has shed some light on a longtime concern of the FDA that taking prescription drugs for uses unapproved by the regulatory agency may do more harm than good.  In fact, researchers from McGill University in Montreal, Harvard Medical School, and MCPHS University who led …. Read More

Comments Off on New Study Finds Off-Label Prescription Drug Use Increases Likelihood of Adverse Events
Contact Us
Web Analytics